APEX1 and cancer: It has been established that amino acid substitutions in the active site of APE1 lead to APE1 activity deficiencies [21] associated with an increase in the frequency of spontaneous mutations, with increased susceptibility to cancer, and with reduced survival after exposure to exogenous oxidizing agents [22,23,24,25,26].